Position in HLN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$164,235
New position
Shares Held
17,603
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#313
of 639 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $794,383 across 2 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,163 | $630,148 | |
| 2 | HLN |
Haleon plc
This page
|
17,603 | $164,235 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,235 | 17,603 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||